Infectious Disease Reagents
ABI produces a wide variety of specialized virus reagents, allowing researchers to choose the best preparations for their studies. Available reagents and selected microbiological products include purified virus, purified viral lysate, whole inactivated virus, and high-titer infectious virus preparations. ABI also offers custom start-to-finish virus propagation, purification and characterization services.
We Have Purification Experience With Many Virus Families
- Orthomyxoviridae
- Paramyxoviridae
- Retroviridae
- Poxviridae
- Herpesviridae
- Picornaviridae
- Adenoviridae
- Togaviridae
Quality Assurance for Virus Preparations
Quality Control (QC) testing is a critical part of ABI’s production process. Sterility and Mycoplasma testing is performed on every virus product. Viral inactivation validated by in vitro infectivity assays. Additional assays may be performed, including:
- Infectivity Titer
- Protein Concentration
- Virus Particle Count by Transmission Electron Microscopy (TEM)
For more information, see our Purified Virus FAQs.
Custom Virus Purification and Production
ABI employs experts in virology, mass cell culture, and centrifugal separation and purification to successfully propagate and purify our high-quality custom virus preparations. With a facility capable of accommodating from 10 to 600 liters of suspension cell culture and from 5 to 500 grams of cell pack for adherent cell cultures, ABI is well suited to offer a wide range of custom products and services to fit your needs.
We have many options available for researchers to customize their viral and bacterial preparations to fit their research needs. For more information about how we can create a custom viral preparation suited to your research, see our pages for Custom Virus Production and Custom Virus Inactivation.
Product List
| Catalog # |
Product Name |
Size | Storage | Bio Cat. | Status |
|---|---|---|---|---|---|
| 10-266-000 | Adenovirus-5 Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-265-000 | Chlamydia trachomatis LGV-II 434 Strain Heat-Inactivated Elementary Bodies | 1 mL | -70˚C | ||
| 10-144-000 | CMV AD169 Strain Purified Viral Lysate (1 mg/mL) | 1 mg | -70˚C | ||
| 10-144-PNK | CMV AD169 Strain Purified Viral Lysate (100 µg/mL) | 1 mL | -70˚C | ||
| 10-275-500 | CMV AD169 Strain Purified Virus, β-PL Inactivated | 0.5 mg | -70˚C |
|
|
| 10-272-000 | Dengue-1 Hawaii Strain Purified Viral Lysate | 1 mL | -70˚C |
|
|
| 10-147-000 | EBV B95-8 Strain (Type 1) Purified Viral Lysate | 1 mg | -70˚C | ||
| 10-115-000 | EBV B95-8 Strain (Type 1) Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-250-000 | FeLV Thielen Strain Purified Virus | 1 mg | -70˚C | ||
| 10-241-500 | HHV-6A GS Strain Purified Viral Lysate | 0.5 mg | -70˚C | ||
| 10-177-000 | HIV-1 Ba-L Strain Direct Pelleted Virus (500X) | 1.0 mL | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-124-000 | HIV-1 IIIB Strain Direct Pelleted Virus (1000X) | 1 mL | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-124-PNK | HIV-1 IIIB Strain Direct Pelleted Virus (100X) | 1 mL | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-119-000 | HIV-1 IIIB Strain Purified Viral Lysate | 1 mg | -70˚C | ||
| 10-118-000 | HIV-1 IIIB Strain Purified Virus | 1 mg | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-228-000 | HIV-1 pHXB2D Strain Direct Pelleted Virus (1000X) | 1 mL | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-226-000 | HIV-1 pHXB2D Strain Direct Pelleted Virus (500X) | 1 mL | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-128-000 | HIV-2 NIH-Z Strain Purified Viral Lysate | 1 mg | -70˚C | ||
| 10-127-000 | HIV-2 NIH-Z Strain Purified Virus | 1 mg | -70˚C |
ABiological Substance, Category A UN 2814 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "A" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.1 as "An infectious substance which is transported in a form that, when exposure to it occurs, is capable of causing permanent disability, life-threatening or fatal disease in otherwise healthy humans or animals." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-145-000 | HSV-1 MacIntyre Strain Purified Viral Lysate | 1 mg | -70˚C | ||
| 10-110-000 | HSV-1 MacIntyre Strain Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-146-000 | HSV-2 G Strain Purified Viral Lysate | 1 mg | -70˚C | ||
| 10-111-000 | HSV-2 G Strain Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-113-000 | HTLV-I MT-2 Strain Purified Viral Lysate | 1 mg | -70˚C | ||
| 10-112-000 | HTLV-I MT-2 Strain Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-276-000 | Human Influenza A/2/Japan/305/57 (H2N2) Purified Virus, UV-Inactivated | 1.0 mg | -70˚C |
|
|
| 10-259-000 | Human Influenza A/2/Japan/305/57 Purified Virus (H2N2) | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-201-500 | Human Influenza A/Hong Kong/8/68 Purified Virus (H3N2) | 0.5 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-268-500 | Human Influenza A/New Caledonia/20/99 Purified Virus (H1N1) | 0.5 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-210-500 | Human Influenza A/PR/8/34 Purified Virus (H1N1) | 0.5 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-273-500 | Human Influenza A/PR/8/34 Purified Virus (H1N1), UV-Inactivated | 0.5 mg | -70˚C | ||
| 10-267-500 | Human Influenza A/PR/8/34 Purified Virus (H1N1), β-PL Inactivated | 0.5 mg | -70˚C | ||
| 10-220-500 | Human Influenza B/Lee/40 Purified Virus | 0.5 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-280-500 | Influenza A/California/4/2009 (H1N1) Purified Virus | 0.5 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-281-500 | Influenza A/Mexico/4108/2009 (H1N1) Purified Virus | 0.5 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-263-000 | Neisseria gonorrhoeae Heat-Inactivated Cells | 1 mL | -70˚C | ||
| 10-262-000 | Neisseria gonorrhoeae Viable Cells | 1 mL | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-249-000 | RSV A-2 Strain Direct Pelleted Virus (1000X) | 1 mL | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-248-000 | RSV A-2 Strain Purified Viral Lysate (1 mg/mL) | 1 mg | -70˚C | ||
| 10-248-PNK | RSV A-2 Strain Purified Viral Lysate (100 µg/mL) | 1 mL | -70˚C | ||
| 10-247-000 | RSV A-2 Strain Purified Virus (1 mg/mL) | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-247-PNK | RSV A-2 Strain Purified Virus (100 µg/mL) | 1 mL | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-270-000 | Rubella HPV77 Strain Purified Virus, UV-Inactivated | 1 mg | -70˚C | ||
| 10-150-000 | SIV mac251 Strain Purified Viral Lysate | 1 mg | -70˚C | ||
| 10-149-000 | SIV mac251 Strain Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-153-000 | SRV-1 Macaque Strain Purified Viral Lysate | 1 mg | -70˚C | ||
| 10-152-000 | SRV-1 Macaque Strain Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-218-000 | SRV-2 Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-223-000 | SRV-5 Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-279-001 | Toxoplasma gondii RH strain Purified Tachyzoites Lysate | 1.0 mL | -70˚C |
|
|
| 10-279-025 | Toxoplasma gondii RH strain Purified Tachyzoites Lysate | 25 mL | -70˚C |
|
|
| 10-252-000 | Vaccinia Lister Strain Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-253-000 | Vaccinia Lister Strain Purified Virus, UV-Inactivated | 1 mg | -70˚C | ||
| 10-254-000 | Vaccinia WR Strain Purified Virus | 1 mg | -70˚C |
BBiological Substance, Category B UN 3373 Shipment of this product requires that Advanced Biotechnologies has an Acceptance of Responsibility Form on file for the end user. Please click the "B" your mouse is hovering over for this form. Defined by IATA in DG Regulations 3.6.2.2.2.2 as "An infectious substance which does not meet the criteria for inclusion in Category A." This is not an indication of biosafety level, but of safety as relates to shipping in a properly prepared package. |
|
| 10-255-000 | Vaccinia WR Strain Purified Virus, UV-Inactivated | 1 mg | -70˚C | ||
| 10-282-500 | VZV Rod Strain Purified Viral Lysate | 0.5 mg | -70˚C |
|
|
| 10-283-500 | VZV Rod strain Purified Virus, UV-Inactivated | 0.5 mg | -70˚C |
|


